HQL
Tekla Life Sciences Investors
1W: -6.8%
1M: -15.8%
3M: -12.3%
YTD: +8.9%
1Y: +15.6%
3Y: +88.6%
5Y: +31.6%
$17.68
-0.49 (-2.70%)
Weekly Expected Move ±3.3%
$17
$17
$18
$18
$19
ETF-Level Metrics
AUM$538M
Holdings82
Top 10 Wt24.6%
Beta0.72
% Profitable8%
Coverage84%
Portfolio Valuation
P/E33.0
P/B4.8
P/S8.4
EV/EBITDA33.8
P/FCF38.7
PEG3.03
Profitability & Returns
Gross Margin86.1%
Net Margin-1.3%
ROE-0.8%
ROA-0.5%
ROIC2.1%
Div Yield0.04%
Leverage & Liquidity
Debt/Equity0.37
Debt/Assets0.23
Net Debt/EBITDA-1.2x
Interest Cov-0.2x
Current Ratio3.19
Quick Ratio2.94
Growth (YoY)
Revenue+42.4%
Net Income-10.7%
EPS+5.0%
FCF-2.2%
EBITDA-7.8%
Rev CAGR 3Y+43.0%
Quality Scores
Piotroski F3.4
Altman Z18.99
IS Quality45.7
IS Overall40.5
IS Value34.6
Median P/E-7.4
Sector Breakdown
3 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Healthcare | 80 | 86.4% | -11.6 |
| Other | 61 | 13.0% | — |
| Financial Services | 2 | 0.7% | 10.4 |
Smart Money Overlap
0 holdings with signalsNo holdings with active convergence signals
Showing 50 of 143 holdings
· Page 1 of 3
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | Insmed Inc | 0JAV.L | 3.04% | $17.0M | 104,142 | -27.0 | $23.7B | Healthcare |
| 2 | Vaxcyte Inc | PCVX | 2.97% | $16.7M | 286,930 | -7.4 | $8.2B | Healthcare |
| 3 | uniQure NV | 0EE0.L | 2.84% | $15.9M | 972,920 | -5.8 | $1.4B | Healthcare |
| 4 | Argenx SE | ARGNF | 2.56% | $14.3M | 19,643 | 33.3 | $58.2B | Healthcare |
| 5 | Dyne Therapeutics Inc | DYN | 2.47% | $13.9M | 763,959 | -4.6 | $2.8B | Healthcare |
| 6 | Denali Therapeutics Inc | DNLI | 2.28% | $12.8M | 664,716 | -7.0 | $3.2B | Healthcare |
| 7 | Axsome Therapeutics Inc | 0HKF.L | 2.22% | $12.5M | 73,746 | -47.8 | $8.8B | Healthcare |
| 8 | Xenon Pharmaceuticals Inc | XENE | 2.10% | $11.8M | 202,664 | -8.0 | $3.7B | Healthcare |
| 9 | Fulcrum Therapeutics Inc | FULC | 2.08% | $11.6M | 1,518,506 | -3.0 | $282M | Healthcare |
| 10 | Tectonic Therapeutic Inc | TECX | 2.04% | $11.5M | 370,884 | -4.9 | $425M | Healthcare |
| 11 | NEUROVANCE MILESTONE INTEREST Private | — | 2.04% | $11.5M | 34,055 | — | — | — |
| 12 | Crinetics Pharmaceuticals Inc | CRNX | 2.02% | $11.3M | 312,153 | -16.8 | $9.0B | Healthcare |
| 13 | Edgewise Therapeutics Inc | EWTX | 1.98% | $11.1M | 353,076 | -22.4 | $4.5B | Healthcare |
| 14 | Immunovant Inc | IMVT | 1.96% | $11.0M | 441,498 | -11.9 | $6.9B | Healthcare |
| 15 | Alnylam Pharmaceuticals Inc | 0HD2.L | 1.78% | $10.0M | 30,216 | 36.0 | $29.7B | Healthcare |
| 16 | Cytokinetics Inc | CYTK | 1.76% | $9.9M | 150,025 | -9.1 | $8.2B | Healthcare |
| 17 | VeraDermics Inc | MANE | 1.75% | $9.8M | 155,623 | — | $4.9B | Healthcare |
| 18 | Regeneron Pharmaceuticals Inc | 0R2M.L | 1.71% | $9.6M | 12,398 | 17.6 | $79.6B | Healthcare |
| 19 | BioCryst Pharmaceuticals Inc | BCRX | 1.69% | $9.5M | 996,017 | -5.7 | $2.1B | Healthcare |
| 20 | Personalis Inc | PSNL | 1.63% | $9.1M | 1,430,790 | -14.9 | $1.7B | Healthcare |
| 21 | Praxis Precision Medicines Inc | PRAX | 1.62% | $9.1M | 28,244 | -22.8 | $8.2B | Healthcare |
| 22 | Sarepta Therapeutics Inc | 0L35.L | 1.62% | $9.1M | 416,313 | -12.2 | $1.8B | Healthcare |
| 23 | Arrowhead Pharmaceuticals Inc | 0HI3.L | 1.60% | $9.0M | 143,265 | -28.7 | $9.0B | Healthcare |
| 24 | EyePoint Inc | EYPT | 1.42% | $7.9M | 616,005 | -0.9 | $272M | Healthcare |
| 25 | Shattuck Labs Inc | STTK | 1.33% | $7.5M | 1,159,321 | -13.2 | $608M | Healthcare |
| 26 | Ideaya Biosciences Inc | IDYA | 1.25% | $7.0M | 210,611 | -19.5 | $3.6B | Healthcare |
| 27 | VERADERMICS, INC. Private | — | 1.23% | $6.9M | 109,305 | — | — | — |
| 28 | Oculis Holding AG | OCS | 1.20% | $6.7M | 253,740 | -5.2 | $499M | Healthcare |
| 29 | Sionna Therapeutics Inc | SION | 1.20% | $6.7M | 168,051 | -2.3 | $222M | Healthcare |
| 30 | Equillium Inc | EQ | 1.20% | $6.7M | 3,352,837 | -5.5 | $89M | Healthcare |
| 31 | Syndax Pharmaceuticals Inc | SNDX | 1.20% | $6.7M | 286,969 | -7.0 | $1.6B | Healthcare |
| 32 | Amgen Inc | 4332.HK | 1.17% | $6.6M | 18,629 | — | $998.5B | Healthcare |
| 33 | Biohaven Ltd | BHVN | 1.16% | $6.5M | 771,452 | -2.8 | $1.9B | Healthcare |
| 34 | Abivax SA | ABVX | 1.16% | $6.5M | 58,444 | -17.7 | $6.8B | Healthcare |
| 35 | Apogee Therapeutics Inc | APGE | 1.15% | $6.5M | 76,841 | -31.1 | $8.4B | Healthcare |
| 36 | Disc Medicine Inc | IRON | 1.13% | $6.4M | 99,339 | -9.8 | $2.5B | Healthcare |
| 37 | Travere Therapeutics Inc | TVTX | 1.08% | $6.1M | 203,913 | -126.5 | $5.3B | Healthcare |
| 38 | Precision BioSciences Inc | DTIL | 1.07% | $6.0M | 1,085,970 | -2.3 | $174M | Healthcare |
| 39 | Structure Therapeutics Inc | GPCR | 1.03% | $5.8M | 119,693 | -9.1 | $1.6B | Healthcare |
| 40 | Nuvalent Inc | NUVL | 1.02% | $5.7M | 55,694 | -20.5 | $9.1B | Healthcare |
| 41 | Adaptive Biotechnologies Corp | ADPT | 0.98% | $5.5M | 394,969 | -69.6 | $4.5B | Healthcare |
| 42 | ARS Pharmaceuticals Inc | SBTX | 0.91% | $5.1M | 638,505 | -2.7 | $550M | Healthcare |
| 43 | Corbus Pharmaceuticals Holdings Inc | 0SZI.L | 0.91% | $5.1M | 543,719 | -0.9 | $77M | Healthcare |
| 44 | Newamsterdam Pharma Co NV | NAMS | 0.90% | $5.0M | 157,389 | -10.6 | $2.7B | Healthcare |
| 45 | Codexis Inc | 0I0X.L | 0.90% | $5.0M | 3,090,272 | -4.0 | $122M | Healthcare |
| 46 | IMMUNIC Private | — | 0.88% | $4.9M | 4,444,604 | — | — | — |
| 47 | Taysha Gene Therapies Inc | TSHA | 0.81% | $4.6M | 1,021,063 | -11.0 | $1.5B | Healthcare |
| 48 | Summit Therapeutics Inc | SMMT | 0.81% | $4.5M | 238,231 | -15.0 | $13.4B | Healthcare |
| 49 | CURASEN THERAPEUTICS, INC. Private | — | 0.77% | $4.3M | 9,049,182 | — | — | — |
| 50 | Vertex Pharmaceuticals Inc | VX1.DE | 0.73% | $4.1M | 9,163 | 29.1 | $113.3B | Healthcare |